BridgeMD
New treatment option for Posttraumatic Stress Disorder
Official title EMDR Treatment in PTSD Following Cardiac Events
ClinicalTrials.gov ID: NCT04672551
What this study is testing
- What it's testing
- Cardiac events can often result in debilitating and persistent psychological symptoms. A key question involves whether optimal treatment of cardiac-induced posttraumatic stress disorder (PTSD) reduces PTSD symptoms and thereby may offset the risk of recurrent or worsening cardiovascular disease.
- Time commitment: about 36 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Age between 18-70 years
- Men or women
- STEMI (irrespective of troponin, but ST-elevation) or non-STEMI (troponin positive) at the time of the cardiac event, as verified by the cardiologist
- Diagnosis of PTSD caused by the cardiac event
You likely can't join if
- Psychotic disorder, bipolar disorder, substance abuse as measured with the Mini International Neuropsychiatric Interview (M.I.N.I)
- Acute suicidal ideation as assessed with the M.I.N.I.
- Non-selective beta blockers (e.g., propranolol) during the study period
- Ongoing psychological/psychiatric treatment outside of the trial during the study period
- Visionary problems, e.g. strabismus, which does not allow adequate eye movements
- Insufficient knowledge of the German language
See the full eligibility criteria
- Age between 18-70 years
- Men or women
- STEMI (irrespective of troponin, but ST-elevation) or non-STEMI (troponin positive) at the time of the cardiac event, as verified by the cardiologist
- Diagnosis of PTSD caused by the cardiac event
- Psychotic disorder, bipolar disorder, substance abuse as measured with the Mini International Neuropsychiatric Interview (M.I.N.I)
- Acute suicidal ideation as assessed with the M.I.N.I.
- Non-selective beta blockers (e.g., propranolol) during the study period
- Ongoing psychological/psychiatric treatment outside of the trial during the study period
- Visionary problems, e.g. strabismus, which does not allow adequate eye movements
- Insufficient knowledge of the German language
- Expected inability or willingness to follow the study protocol
- Regular medication with benzodiazepine
The study team makes the final eligibility decision.
Where it's taking place
- Zurich, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 36 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.